1. Home
  2. CREX vs LEXX Comparison

CREX vs LEXX Comparison

Compare CREX & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CREX
  • LEXX
  • Stock Information
  • Founded
  • CREX N/A
  • LEXX 2004
  • Country
  • CREX United States
  • LEXX Canada
  • Employees
  • CREX N/A
  • LEXX N/A
  • Industry
  • CREX EDP Services
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CREX Technology
  • LEXX Health Care
  • Exchange
  • CREX Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • CREX 25.7M
  • LEXX 23.9M
  • IPO Year
  • CREX N/A
  • LEXX N/A
  • Fundamental
  • Price
  • CREX N/A
  • LEXX $0.91
  • Analyst Decision
  • CREX Strong Buy
  • LEXX Strong Buy
  • Analyst Count
  • CREX 1
  • LEXX 1
  • Target Price
  • CREX $6.00
  • LEXX $4.00
  • AVG Volume (30 Days)
  • CREX 33.3K
  • LEXX 1.3M
  • Earning Date
  • CREX 11-12-2025
  • LEXX 11-25-2025
  • Dividend Yield
  • CREX N/A
  • LEXX N/A
  • EPS Growth
  • CREX N/A
  • LEXX N/A
  • EPS
  • CREX N/A
  • LEXX N/A
  • Revenue
  • CREX $48,218,000.00
  • LEXX $615,923.00
  • Revenue This Year
  • CREX $4.82
  • LEXX $46.98
  • Revenue Next Year
  • CREX $18.60
  • LEXX $17.26
  • P/E Ratio
  • CREX N/A
  • LEXX N/A
  • Revenue Growth
  • CREX N/A
  • LEXX 49.85
  • 52 Week Low
  • CREX $1.28
  • LEXX $0.77
  • 52 Week High
  • CREX $4.75
  • LEXX $3.24
  • Technical
  • Relative Strength Index (RSI)
  • CREX N/A
  • LEXX 40.41
  • Support Level
  • CREX N/A
  • LEXX $0.80
  • Resistance Level
  • CREX N/A
  • LEXX $1.01
  • Average True Range (ATR)
  • CREX 0.00
  • LEXX 0.11
  • MACD
  • CREX 0.00
  • LEXX -0.06
  • Stochastic Oscillator
  • CREX 0.00
  • LEXX 3.49

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: